Does DABIGATRAN ETEXILATE Cause Dyspepsia? 355 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 355 reports of Dyspepsia have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.0% of all adverse event reports for DABIGATRAN ETEXILATE.
355
Reports of Dyspepsia with DABIGATRAN ETEXILATE
1.0%
of all DABIGATRAN ETEXILATE reports
7
Deaths
74
Hospitalizations
How Dangerous Is Dyspepsia From DABIGATRAN ETEXILATE?
Of the 355 reports, 7 (2.0%) resulted in death, 74 (20.8%) required hospitalization, and 5 (1.4%) were considered life-threatening.
Is Dyspepsia Listed in the Official Label?
Yes, Dyspepsia is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Dyspepsia?
ADALIMUMAB (3,586)
METHOTREXATE (2,690)
RITUXIMAB (2,289)
TOFACITINIB (2,264)
PREDNISONE (2,224)
APREMILAST (2,207)
ETANERCEPT (2,100)
ESOMEPRAZOLE (2,064)
TOCILIZUMAB (2,046)
LEFLUNOMIDE (1,981)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Dyspepsia Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB